SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-022908
Filing Date
2022-08-15
Accepted
2022-08-15 16:32:55
Documents
23
Period of Report
2022-08-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 121947
2 ex1-1.htm EX-1.1 308992
3 ex3-1.htm EX-3.1 132366
4 ex3-2.htm EX-3.2 133782
5 ex3-3.htm EX-3.3 112314
6 ex4-1.htm EX-4.1 154141
7 ex5-1.htm EX-5.1 14819
8 ex10-1.htm EX-10.1 267154
9 ex10-2.htm EX-10.2 175576
10 ex99-1.htm EX-99.1 67665
11 ex5-1_001.jpg GRAPHIC 9616
12 ex5-1_002.jpg GRAPHIC 69408
  Complete submission text file 0001493152-22-022908.txt   2076397

Data Files

Seq Description Document Type Size
13 XBRL SCHEMA FILE sonn-20220815.xsd EX-101.SCH 2962
14 XBRL LABEL FILE sonn-20220815_lab.xml EX-101.LAB 34916
15 XBRL PRESENTATION FILE sonn-20220815_pre.xml EX-101.PRE 22791
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3907
Mailing Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540
Business Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540 609-375-2227
Sonnet BioTherapeutics Holdings, Inc. (Filer) CIK: 0001106838 (see all company filings)

IRS No.: 522102141 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-35570 | Film No.: 221166103
SIC: 2834 Pharmaceutical Preparations